HER2-Positive Breast Cancer and CDK4/6 Inhibitors

Videos — January 10, 2018

Featuring:

Dr Hope Rugo discusses studies that are aiming to evaluate the effect that CDK4/6 inhibitors have on patients with HER2-positive breast cancer.

Related Articles